BellRing Brands (BRBR) Shares Drop -43% After Earnings Miss and Guidance Cut
Key Takeaways
- BellRing Brands (BRBR) shares plunged 43.09% to $9.88 in the most recent trading session.
- The primary catalyst was a disappointing Q2 fiscal 2026 earnings report, with adjusted EPS of $0.14 missing estimates of $0.31 by 55% and revenue of $598.7 million falling short of $608.8 million expectations.
- Company cut its full-year 2026 revenue guidance to $2.33-$2.37 billion from prior $2.41-$2.46 billion, citing promotional headwinds, input cost inflation, and freight pressures.
- Trading volume surged to over 12 million shares, well above the three-month average of 3.56 million.
- The move diverged sharply from consumer staples peers and the XLP ETF, which showed minimal change.
- Traders are watching the earnings conference call for further commentary on margin pressures and recovery plans.
The Sharp Decline in BRBR Shares
BellRing Brands, Inc. (BRBR), known for its convenient nutrition products such as Premier Protein shakes and Dymatize powders, experienced a significant drop in its stock price. Shares fell 43.09% to $9.88 during Monday's trading session, down from a prior close of $17.36. This reaction stemmed directly from the company's second-quarter fiscal 2026 earnings miss and a downward revision to its full-year guidance. From what I see, investors are clearly concerned about slowing growth and profitability pressures in the protein nutrition segment.
Breaking Down the Earnings Miss and Revised Outlook
In Q2 fiscal 2026, BellRing Brands reported net sales of $598.7 million, reflecting just a 1.8% year-over-year increase but missing the consensus estimate of $598.8 million. Adjusted EPS came in at $0.14, representing a 55.3% shortfall against expectations of $0.31. One thing that stands out is the sharp contraction in gross margins, which fell to 22.7% from 34.5% a year earlier, driven by higher protein and freight costs along with increased promotional activity.
The company also adjusted its fiscal 2026 outlook, narrowing revenue guidance to $2.33-$2.37 billion—about 2.9% below prior analyst forecasts—and Adjusted EBITDA to $315-$335 million. Management pointed to ongoing consumer headwinds, inflation on key inputs, and investments in advertising as key factors, noting that the guidance does not assume recovery from recent inventory issues. I also checked this using Tickeron’s AI Screener to see how BRBR compares to others in the industry, and the margin pressures appear more acute here.
Trading Volume and Market Reaction
Trading volume spiked to 12 million shares, more than triple the three-month average of 3.56 million, indicating strong selling pressure following the earnings release. This plunge stood out against the broader market and sector, where the Consumer Staples Select Sector SPDR ETF (XLP) remained flat around $83.64. Among peers, Post Holdings (POST) dipped slightly to $102.09, Monster Beverage (MNST) edged up to $76.27, and USANA Health (USNA) held near $18.60, highlighting the company-specific nature of BRBR's decline. Technically, shares broke below key support near $17, with heightened volatility despite a beta of 0.81.
Exploring Tickeron’s Trending AI Robots
In my own research process, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI-driven trading bots tailored to current market conditions. Tickeron provides hundreds of these AI bots, covering thousands of tickers across strategies like momentum, mean reversion, and pattern recognition, across various timeframes and performance metrics. Only the strongest, most adaptive ones make the curated list, which is particularly useful in volatile situations like earnings-driven moves. I’m watching this closely because it helps me identify tools that deliver data-backed insights without relying on guesswork—check out the real-time rankings, backtested results, and bot details there for yourself.
Looking Ahead for BRBR
Investors will want to tune into the Q2 earnings conference call at 8:30 a.m. ET for more details on cost management and demand trends. The next quarterly results are scheduled for early August 2026. In my view, analyst consensus is turning cautious after the guidance cut, with emphasis on execution in a competitive protein category. Broader sector risks persist, including inflation and shifting consumer preferences toward value options. Uncertainties around promotional effectiveness and supply chain costs remain, though long-term potential exists in household penetration for ready-to-drink nutrition if margins can stabilize. This is important because it underscores the need for disciplined monitoring.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
BRBR's RSI Oscillator is staying in oversold zone for 2 days
It is expected that a price bounce should occur soon.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BRBR advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .
BRBR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on May 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BRBR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for BRBR turned negative on May 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .
BRBR moved below its 50-day moving average on May 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BRBR crossed bearishly below the 50-day moving average on May 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BRBR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BRBR entered a downward trend on April 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (37.427). P/E Ratio (8.109) is within average values for comparable stocks, (36.059). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.398). BRBR has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.039). P/S Ratio (0.550) is also within normal values, averaging (38.396).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BRBR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BRBR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry FoodMajorDiversified
Advertisement